Nirvana Life Sciences Inc.
NIRVF
$0.0083
$0.000.00%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -337.90K | -417.20K | -646.90K | -910.50K | -1.09M |
| Total Depreciation and Amortization | 13.50K | 13.50K | 13.50K | 25.90K | 33.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.90K | 60.40K | 228.20K | 612.80K | 721.40K |
| Change in Net Operating Assets | 245.10K | 280.00K | 264.00K | 84.10K | 133.10K |
| Cash from Operations | -32.40K | -63.30K | -141.30K | -187.70K | -199.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 49.50K | 25.50K | 28.20K | -9.50K | 11.90K |
| Total Debt Repaid | 50.00K | 50.00K | 0.00 | -50.00K | -50.00K |
| Issuance of Common Stock | 0.00 | 25.00K | 210.10K | 320.00K | 320.00K |
| Repurchase of Common Stock | -59.10K | -59.10K | -59.10K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.10K | 9.10K | 0.00 | -9.10K | -9.10K |
| Cash from Financing | 36.30K | 37.10K | 133.80K | 187.20K | 203.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -11.30K | -2.20K | -- | -- | -- |
| Net Change in Cash | -7.40K | -28.30K | -7.40K | -400.00 | 3.30K |
